CNTN
Canton Strategic Holdings, Inc.
Price Chart
Latest Quote
$3.35
| Previous Close | $3.54 |
| Open | $3.48 |
| Day High | $3.50 |
| Day Low | $3.18 |
| Volume | 2,762,822 |
Stock Information
| Shares Outstanding | 69.80M |
| Cash Equivalents | $41.53M |
| Net Income | $-80.72M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $233.85M |
| EPS (TTM) | $-0.36 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $188.82M |
| Income | $-80.72M |
| Book/sh | $8.29 |
| Cash/sh | $0.59 |
| Employees | 12 |
Financial Ratios
| Quick Ratio | 36.39 |
| Current Ratio | 37.75 |
Returns & Margins
| ROA | -11.60% |
| ROE | -34.42% |
Ownership
| Insider Ownership | 19.20% |
| Institutional Ownership | 18.29% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/B | 0.40 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $2.99 |
| SMA50 | $3.19 |
| SMA200 | $3.31 |
| RSI | 55.23 |
| ATR | 0.3911 |
| Shares Float | 62.84M |
| Short Float | 4.66% |
| Short Ratio | 6.07 |
| Volatility | 1.43 |
| Rel Volume | 2.52 |
Performance History
| Week | +10.93% |
| Month | +2.60% |
| Quarter | -0.89% |
| 6 Months | +39.00% |
| YTD | -0.89% |
| Year | +132.64% |
| 3 Years | -97.74% |
| 10 Years | -99.74% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $3.35 | 2,767,000 |
| 2026-06-17 | $3.54 | 1,385,900 |
| 2026-06-16 | $3.30 | 2,286,400 |
| 2026-06-15 | $3.21 | 1,007,500 |
| 2026-06-12 | $3.09 | 777,300 |
| 2026-06-11 | $3.02 | 1,171,100 |
| 2026-06-10 | $2.95 | 1,024,700 |
| 2026-06-09 | $2.68 | 994,100 |
| 2026-06-08 | $2.65 | 988,200 |
| 2026-06-05 | $2.30 | 920,000 |
| 2026-06-04 | $2.45 | 669,900 |
| 2026-06-03 | $2.45 | 657,100 |
| 2026-06-02 | $2.37 | 2,615,300 |
| 2026-06-01 | $2.81 | 1,491,600 |
| 2026-05-29 | $3.10 | 754,100 |
| 2026-05-28 | $3.11 | 631,400 |
| 2026-05-27 | $3.23 | 551,100 |
| 2026-05-26 | $3.29 | 382,100 |
| 2026-05-22 | $3.52 | 610,800 |
| 2026-05-21 | $3.35 | 264,000 |
| 2026-05-20 | $3.25 | 260,000 |
| 2026-05-19 | $3.27 | 357,100 |
About Canton Strategic Holdings, Inc.
Canton Strategic Holdings, Inc. engages in the institutional blockchain adoption and digitization of financial markets in the United States. It operates in two segments, Digital Asset Treasury and Clinical Stage Bio-technology. The company is involved in the operation of Canton Coin-centric digital asset treasury strategies, including validator operations and network participation; application support and strategic investments; collaboration and ecosystem advancement; capital raising and treasury expansion; token management - locking, lending, and options; Canton Foundation; and governance and risk management. It also researches and develops GV104, a buccal film formulation of nalmefene for the treatment of respiratory depression and prophylactic protection against synthetic opioid exposure in military and first responders; and GV023, an oral anti-tumor necrosis factor-alpha monoclonal antibody that addresses critical limitation of IV gold standard for the treatment of repeated intravenous infusions. The company was formerly known as Tharimmune, Inc. and changed its name to Canton Strategic Holdings, Inc. in February 2026. Canton Strategic Holdings, Inc. was incorporated in 2017 and is headquartered in Red Bank, New Jersey.
đ° Latest News
We're Not Very Worried About Canton Strategic Holdings' (NASDAQ:CNTN) Cash Burn Rate
Simply Wall St. âĸ 2026-05-15T12:04:14ZTharimmune Highlights Canton Network Q1 Growth, Tokenomics Shift and Validator Locking in Webinar
MarketBeat âĸ 2026-04-26T02:02:15ZCrypto Currents: SEC, CFTC sign MOU for Joint Harmonization Initiative
TipRanks âĸ 2026-03-14T14:32:35ZIncome Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Interest Expense | $28,345 | $13,684 | $16,505 | $1,591,244 |
| Total Expenses | $20,106,066 | $12,433,792 | $9,455,220 | $6,881,938 |
| Other Income Expense | $-22,010,362 | - | - | - |
| Other Non Operating Income Expenses | $-22,010,362 | - | - | - |
| Net Non Operating Interest Income Expense | $13,065 | $236,224 | $136,126 | $-1,591,244 |
| Interest Expense Non Operating | $28,345 | $13,684 | $16,505 | $1,591,244 |
| Operating Expense | $20,106,066 | $12,433,792 | $9,455,220 | $6,881,938 |
| General And Administrative Expense | $17,032,102 | $6,041,695 | $5,895,585 | $4,603,514 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-35,916,250 | $-12,197,568 | $-9,319,094 | $-8,473,182 |
| Net Interest Income | $13,065 | $236,224 | $136,126 | $-1,591,244 |
| Interest Income | $41,410 | $249,908 | $152,631 | $0 |
| Normalized Income | $-35,916,250 | $-12,197,568 | $-9,319,094 | $-8,473,182 |
| Net Income From Continuing And Discontinued Operation | $-35,916,250 | $-12,197,568 | $-9,319,094 | $-8,473,182 |
| Total Operating Income As Reported | $-20,106,066 | $-12,433,792 | $-9,455,220 | $-6,881,938 |
| Net Income Common Stockholders | $-35,916,250 | $-12,197,568 | $-9,319,094 | $-8,473,182 |
| Net Income | $-35,916,250 | $-12,197,568 | $-9,319,094 | $-8,473,182 |
| Net Income Including Noncontrolling Interests | $-35,916,250 | $-12,197,568 | $-9,319,094 | $-8,473,182 |
| Net Income Continuous Operations | $-35,916,250 | $-12,197,568 | $-9,319,094 | $-8,473,182 |
| Pretax Income | $-42,103,363 | $-12,197,568 | $-9,319,094 | $-8,473,182 |
| Interest Income Non Operating | $41,410 | $249,908 | $152,631 | $0 |
| Operating Income | $-20,106,066 | $-12,433,792 | $-9,455,220 | $-6,881,938 |
| Special Income Charges | - | - | - | - |
| Per Share | ||||
| Diluted EPS | $-1.12 | $-9.41 | $-107.02 | $-280.80 |
| Basic EPS | $-1.12 | $-9.41 | $-107.02 | $-280.80 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-42,075,018 | $-12,183,884 | $-9,302,589 | $-6,881,938 |
| EBITDA (Bullshit earnings) | $-42,075,018 | $-12,183,884 | $-9,302,589 | $-6,881,938 |
| EBIT | $-42,075,018 | $-12,183,884 | $-9,302,589 | $-6,881,938 |
| Diluted Average Shares | $32,049,310 | $1,296,290 | $87,079 | $30,179 |
| Basic Average Shares | $32,049,310 | $1,296,290 | $87,079 | $30,179 |
| Diluted NI Availto Com Stockholders | $-35,916,250 | $-12,197,568 | $-9,319,094 | $-8,473,182 |
| Tax Provision | $-6,187,113 | $0 | - | - |
| Research And Development | $3,073,964 | $6,392,097 | $3,559,635 | $2,278,424 |
| Selling General And Administration | $17,032,102 | $6,041,695 | $5,895,585 | $4,603,514 |
| Other Gand A | $17,032,102 | $6,041,695 | $5,895,585 | $4,603,514 |
| Total Unusual Items | - | - | - | - |
| Total Unusual Items Excluding Goodwill | - | - | - | - |
| Restructuring And Mergern Acquisition | - | - | - | - |
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-103,834,489 | $1,307,642 | $9,131,347 | $5,543,655 |
| Total Assets | $519,146,435 | $3,721,624 | $10,946,393 | $6,688,628 |
| Total Non Current Assets | $501,760,369 | $0 | $0 | $0 |
| Goodwill And Other Intangible Assets | $501,760,369 | $0 | - | - |
| Other Intangible Assets | $501,760,369 | - | - | - |
| Current Assets | $17,386,066 | $3,721,624 | $10,946,393 | $6,688,628 |
| Other Current Assets | $353,318 | $45,263 | $11,041 | $178,094 |
| Current Deferred Assets | $0 | $117,000 | $0 | $0 |
| Cash Cash Equivalents And Short Term Investments | $17,032,748 | $3,559,361 | $10,935,352 | $6,510,534 |
| Cash And Cash Equivalents | $17,032,748 | $3,559,361 | $10,935,352 | $6,510,534 |
| Cash Financial | $17,032,748 | $3,559,361 | $10,935,352 | $6,510,534 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | - | - | - | - |
| Total Debt | - | - | - | - |
| Long Term Debt And Capital Lease Obligation | - | - | - | - |
| Long Term Debt | - | - | - | - |
| Current Debt And Capital Lease Obligation | - | - | - | - |
| Current Debt | - | - | - | - |
| Other Current Borrowings | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $121,220,555 | $2,413,982 | $1,815,046 | $1,144,973 |
| Total Non Current Liabilities Net Minority Interest | $117,934,191 | $0 | $0 | $0 |
| Non Current Deferred Liabilities | $117,934,191 | $0 | - | - |
| Non Current Deferred Taxes Liabilities | $117,934,191 | $0 | - | - |
| Current Liabilities | $3,286,364 | $2,413,982 | $1,815,046 | $1,144,973 |
| Payables And Accrued Expenses | $3,286,364 | $2,413,982 | $1,815,046 | $1,144,973 |
| Payables | $1,090,274 | $1,089,666 | $908,577 | $954,505 |
| Accounts Payable | $1,090,274 | $1,089,666 | $908,577 | $954,505 |
| Interest Payable | - | - | - | $0 |
| Other Current Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $397,925,880 | $1,307,642 | $9,131,347 | $5,543,655 |
| Total Equity Gross Minority Interest | $397,925,880 | $1,307,642 | $9,131,347 | $5,543,655 |
| Stockholders Equity | $397,925,880 | $1,307,642 | $9,131,347 | $5,543,655 |
| Retained Earnings | $-72,817,344 | $-36,901,094 | $-24,703,526 | $-15,384,432 |
| Other | ||||
| Treasury Shares Number | $246 | $246 | $242 | $242 |
| Ordinary Shares Number | $37,112,220 | $1,973,753 | $782,645 | $30,704 |
| Share Issued | $37,112,466 | $1,973,999 | $782,887 | $30,946 |
| Tangible Book Value | $-103,834,489 | $1,307,642 | $9,131,347 | $5,543,655 |
| Invested Capital | $397,925,880 | $1,307,642 | $9,131,347 | $5,543,655 |
| Working Capital | $14,099,702 | $1,307,642 | $9,131,347 | $5,543,655 |
| Total Capitalization | $397,925,880 | $1,307,642 | $9,131,347 | $5,543,655 |
| Treasury Stock | $69,965 | $69,965 | $69,965 | $69,965 |
| Additional Paid In Capital | $470,809,478 | $38,278,503 | $33,904,749 | $20,998,006 |
| Capital Stock | $3,711 | $198 | $89 | $46 |
| Common Stock | $3,711 | $198 | $89 | $46 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Current Accrued Expenses | $2,196,090 | $1,324,316 | $906,469 | $190,468 |
| Dueto Related Parties Current | - | - | - | $0 |
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-93,700,883 | $-10,901,991 | $-7,300,106 | $-6,557,950 |
| Operating Activities | ||||
| Operating Cash Flow | $-16,128,316 | $-10,901,991 | $-7,300,106 | $-6,557,950 |
| Cash Flow From Continuing Operating Activities | $-16,128,316 | $-10,901,991 | $-7,300,106 | $-6,557,950 |
| Operating Gains Losses | $22,010,362 | - | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-77,572,567 | - | - | - |
| Investing Cash Flow | $-77,572,567 | $0 | $0 | $0 |
| Cash Flow From Continuing Investing Activities | $-77,572,567 | $0 | - | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $115,672,891 | $4,187,729 | $12,234,929 | $13,645,643 |
| Financing Cash Flow | $107,174,270 | $3,526,000 | $11,724,924 | $13,064,128 |
| Cash Flow From Continuing Financing Activities | $107,174,270 | $3,526,000 | $11,724,924 | $13,064,128 |
| Net Other Financing Charges | $-9,981,802 | $-661,729 | $-519,180 | $-521,294 |
| Net Common Stock Issuance | $115,672,891 | $4,187,729 | $12,234,929 | $13,575,678 |
| Common Stock Issuance | $115,672,891 | $4,187,729 | $12,234,929 | $13,645,643 |
| Repurchase Of Capital Stock | - | - | $0 | $-69,965 |
| Other | ||||
| Repayment Of Debt | $-221,869 | $0 | $0 | $-139,645 |
| Interest Paid Supplemental Data | $28,345 | $13,684 | $16,505 | $22,241 |
| End Cash Position | $17,032,748 | $3,559,361 | $10,935,352 | $6,510,534 |
| Beginning Cash Position | $3,559,361 | $10,935,352 | $6,510,534 | $4,356 |
| Changes In Cash | $13,473,387 | $-7,375,991 | $4,424,818 | $6,506,178 |
| Proceeds From Stock Option Exercised | $1,705,050 | $0 | $9,175 | $24,389 |
| Net Issuance Payments Of Debt | $-221,869 | $0 | $0 | $-14,645 |
| Net Long Term Debt Issuance | $-221,869 | $0 | $0 | $-14,645 |
| Long Term Debt Payments | $-221,869 | $0 | $0 | $-139,645 |
| Net Intangibles Purchase And Sale | $-77,572,567 | $0 | - | - |
| Purchase Of Intangibles | $-77,572,567 | $0 | - | - |
| Change In Working Capital | $986,408 | $564,714 | $837,126 | $-569,112 |
| Change In Payables And Accrued Expense | $1,294,463 | $598,936 | $670,073 | $-461,688 |
| Change In Accrued Expense | $1,071,986 | $417,847 | $716,001 | $-120,518 |
| Change In Payable | $222,477 | $181,089 | $-45,928 | $-341,170 |
| Change In Account Payable | $222,477 | $181,089 | $-45,928 | $-141,170 |
| Change In Prepaid Assets | $-308,055 | $-34,222 | $167,053 | $-107,424 |
| Other Non Cash Items | $100,421 | $20,550 | $350,000 | $1,683,648 |
| Stock Based Compensation | $2,877,856 | $710,313 | $831,862 | $800,696 |
| Deferred Tax | $-6,187,113 | $0 | - | - |
| Deferred Income Tax | $-6,187,113 | $0 | - | - |
| Gain Loss On Sale Of PPE | $22,010,362 | $0 | - | - |
| Net Income From Continuing Operations | $-35,916,250 | $-12,197,568 | $-9,319,094 | $-8,473,182 |
| Issuance Of Debt | - | - | $0 | $125,000 |
| Common Stock Payments | - | - | $0 | $-69,965 |
| Long Term Debt Issuance | - | - | $0 | $125,000 |
| Change In Interest Payable | - | - | $0 | $7,237 |